Baxter forecast 2026 profit below estimates
Feb 12 (Reuters) - Medical products maker Baxter forecast annual profit below Wall Street estimates on Thursday, due to persistent impact from hurricane-related disruptions at a key manufacturing unit.
Baxter expects 2026 adjusted profit between $1.85 and $2.05 per share, well below analysts' average expectation of $2.25 per share, according to data compiled by LSEG.
(Reporting by Kamal Choudhury in Bengaluru)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Camiones cargados de soja esperan en puerto fluvial de Brasil, ralentizando envíos de cosecha récord
US Court Jails Incognito Market Operator for 30 Years After Tracing Crypto Transactions
Daily short sale tracking: NVIDIA's short volume increased by 15 million, with a short sale ratio of 11%
Hyperliquid price eyes $30 breakout amid HIP-6 token launch vote
Trending news
MoreCrypto prices
More
